Instrument Inactif

Autres langues IMARA

Actions

IMRA

US45249V1070

Autres langues

24/02/23	Enliven Therapeutics Completes Merger With Imara
23/02/23	IMARA Inc.(NasdaqGS:IMRA) dropped from NASDAQ Composite Index
23/02/23	Enliven Therapeutics, Inc. completed the acquisition of IMARA Inc. from a group of shareholders for approximately $340 million in a reverse merger transaction.
22/02/23	IMARA INC. : Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
22/02/23	Imara Announces Stockholder Approval of Merger With Enliven
22/02/23	Imara Announces Stockholder Approval of Merger With Enliven
13/02/23	IMARA INC. : Other Events (form 8-K)
10/02/23	IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
10/02/23	IMARA Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
25/01/23	IMARA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA
09/01/23	Top Premarket Decliners
05/12/22	IMARA INC. : Other Events (form 8-K)
16/11/22	IMARA INC. Financial Statements and Exhibits (form 8-K/A)
10/11/22	IMARA INC. : Completion of Acquisition or Disposition of Assets, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
10/11/22	Cardurion Pharmaceuticals, LLC acquired Tovinontrine (IMR-687) and All of the Assets Related to PDE9 Program from IMARA Inc. for approximately $95.
25/10/22	IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
25/10/22	IMARA Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
15/10/22	IMARA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA
14/10/22	Sector Update: Health Care Stocks Ending with Modest Declines
14/10/22	Top Midday Gainers
14/10/22	Wall Street Set to Open Higher as Earnings Season Accelerates, Ahead of Consumer Sentiment Survey
14/10/22	US Stock Futures Mixed as Earnings Season Accelerates, Ahead of Consumer Sentiment Survey
14/10/22	Top Premarket Gainers
14/10/22	IMARA INC. : Other Events, Financial Statements and Exhibits (form 8-K)
14/10/22	Arix Bioscience Portfolio Company Imara To Merge With Enliven Therapeutics

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Autres langues IMARA

Actions

IMRA

US45249V1070

Autres langues

Filtres